Publication

Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Sylvia M. LaCourse, University of WashingtonLisa Marie Cranmer, Emory UniversityDaniel Matemo, Kenyatta National HospitalJohn Kinuthia, Kenyatta National HospitalBarbra A. Richardson, University of WashingtonDavid J. Horne, University of WashingtonGrace John-Stewart, University of Washington
Language
  • English
Date
  • 2017-05-01
Publisher
  • Lippincott, Williams & Wilkins
Publication Version
Copyright Statement
  • © 2017 The Author(s). Published by Wolters Kluwer Health, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1525-4135
Volume
  • 75
Issue
  • 1
Start Page
  • 128
End Page
  • 136
Grant/Funding Information
  • This work was supported by the National Institute of Allergy and Infectious Diseases and the National Institute of Child Health and Human Development at the National Institutes of Health [K23 AI 120793-01 and T32 AI07140 to SML, K23 AI 85036-01 to DJH, K24 HD054314-06 to GJS, K12 HD000850 to LMC], University of Washington Center for AIDS Research (CFAR) P30AI027757 to SML, UW INTERSECT-Ellison Fellowship to SML, the National Center for Research Resources at the National Institutes of Health [UL1TR000423] and the Firland Foundation.
Supplemental Material (URL)
Abstract
  • Background: Peripartum immunologic changes may affect latent tuberculosis infection (LTBI) diagnostic performance among HIVinfected women. Methods: HIV-infected women were serially tested with tuberculin skin test (TST) and interferon gamma release assay [QuantiFERON TB Gold In-tube (QFT)] in pregnancy and 6 weeks postpartum in Kenya. Prevalence, sensitivity and agreement, and correlates of QFT/TST positivity were assessed. Quantitative QFT mitogen and Mycobacterium tuberculosis antigen (Mtb-Ag) responses were compared by peripartum stage. Incidence of test conversion at 6 weeks postpartum was evaluated in baseline TST2/QFT2 women. Results: Among 100 HIV-infected women, median age was 26 years, median CD4 was 555 cells per cubic millimeter, and 88% were on antiretrovirals. More women were QFT+ than TST+ in both pregnancy (35.4% vs. 13.5%, P = 0.001) and postpartum (29.6% vs. 14.8%, P , 0.001). Among 18 consistently QFT+ women, 8 (44%) converted from TST2 to TST+, with improved test agreement postpartum (56.9%, k = 0.20 to 82.4%, k = 0.60). Three initially QFT2/TST2 women had test conversion (TST+ and/or QFT+), suggesting new infection (incidence 13.4/100 person-years). Mean QFT mitogen (4.46 vs. 7.64 IU/mL, P , 0.001) and Mtb-Ag (1.03 vs. 1.54 IU/mL, P = 0.03) responses were lower among all women retested in pregnancy vs. postpartum, and specifically among persistently QFT+ women (Mtb-Ag: 3.46 vs. 4.48 IU/mL, P = 0.007). QFT indeterminate rate was higher in pregnancy (16%) compared with postpartum (0%) because of lower mitogen response. Conclusions: QFT identified .2-fold more women with LTBI compared with TST in pregnancy and postpartum. Lower QFT Mtb-Ag and mitogen responses in pregnancy compared with postpartum suggest that pregnancy-associated immunologic changes may influence LTBI test performance.
Author Notes
  • CORRESPONDING AUTHOR/REPRINT REQUEST: Sylvia LaCourse, University of Washington, 325 9th Avenue, Box 359931, Seattle, WA 98104; sylvial2@uw.edu; 206-616-5978 (phone), 206-543-4818 (fax).
Keywords
Research Categories
  • Health Sciences, Obstetrics and Gynecology
  • Biology, Biostatistics
  • Health Sciences, Immunology

Tools

Relations

In Collection:

Items